Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2013 (2013), Article ID 295791, 6 pages
http://dx.doi.org/10.1155/2013/295791
Research Article

The Vitamin D Receptor (VDR) Gene Polymorphisms in Turkish Brain Cancer Patients

1Department of Molecular Medicine, The Institute of Experimental Medicine, İstanbul University, Vakıf Gureba Caddesi, Capa, 34390 Istanbul, Turkey
2Department of Neurosurgery, Cerrahpaşa Faculty of Medicine, İstanbul University, Istanbul, Turkey

Received 25 September 2012; Revised 30 January 2013; Accepted 25 March 2013

Academic Editor: Daniel Prá

Copyright © 2013 Bahar Toptaş et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. A. McKinney, “Brain tumours: incidence, survival, and aetiology,” Neurology in Practice, vol. 75, no. 2, pp. 12–17, 2004. View at Google Scholar · View at Scopus
  2. S. R. Chandana, S. Movva, M. Arora, and T. Singh, “Primary brain tumors in adults,” American Family Physician, vol. 77, no. 10, pp. 1423–1430, 2008. View at Google Scholar · View at Scopus
  3. J. L. Fisher, J. A. Schwartzbaum, M. Wrensch, and J. L. Wiemels, “Epidemiology of brain tumors,” Neurologic Clinics, vol. 25, no. 4, pp. 867–890, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. M. L. Goodenberger and R. B. Jenkins, “Genetics of adult glioma,” Cancer Genetics, vol. 205, no. 12, pp. 613–621, 2012. View at Publisher · View at Google Scholar
  5. C. Marosi, M. Hassler, K. Roessler et al., “Meningioma,” Critical Reviews in Oncology/Hematology, vol. 67, no. 2, pp. 153–171, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Rajaraman, B. S. Melin, Z. Wang et al., “Genome-wide association study of glioma and meta-analysis,” Human Genetics, vol. 131, no. 12, pp. 1877–1888, 2012. View at Publisher · View at Google Scholar
  7. H. Pinarbasi, Y. Silig, and M. Gurelik, “Genetic polymorphisms of GSTs and their association with primary brain tumor incidence,” Cancer Genetics and Cytogenetics, vol. 156, no. 2, pp. 144–149, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. K. T. Amor, R. M. Rashid, and P. Mirmirani, “Does D matter? The role of vitamin D in hair disorders and hair follicle cycling,” Dermatology Online Journal, vol. 16, no. 2, article 3, 2010. View at Google Scholar · View at Scopus
  9. L. Vuolo, C. Di Somma, A. Faggiano, and A. Colao, “Vitamin D and cancer,” Frontiers in Endocrinology, vol. 3, p. 58, 2012. View at Publisher · View at Google Scholar
  10. Y. Amano, K. Komiyama, and M. Makishima, “Vitamin D and periodontal disease,” Journal of Oral Science, vol. 51, no. 1, pp. 11–20, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. A. W. Norman, “From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health,” American Journal of Clinical Nutrition, vol. 88, no. 2, 2008. View at Google Scholar · View at Scopus
  12. J. C. Mathers, G. Strathdee, and C. L. Relton, “Induction of epigenetic alterations by dietary and other environmental factors,” Advances in Genetics, vol. 71, pp. 4–39, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. M. L. Slattery, “Vitamin D receptor gene (VDR) associations with cancer,” Nutrition Reviews, vol. 65, no. 8, pp. S102–104, 2007. View at Google Scholar · View at Scopus
  14. K. Köstner, N. Denzer, C. S. L. Müller, R. Klein, W. Tilgen, and J. Reichrath, “The relevance of Vitamin D Receptor (VDR) gene polymorphisms for cancer: a review of the literature,” Anticancer Research, vol. 29, no. 9, pp. 3511–3536, 2009. View at Google Scholar · View at Scopus
  15. K. W. Colston and C. M. Hansen, “Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer,” Endocrine-Related Cancer, vol. 9, no. 1, pp. 45–59, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. M. L. Slattery, C. Sweeney, M. Murtaugh et al., “Associations between vitamin D, vitamin D receptor gene and the androgen receptor gene with colon and rectal cancer,” International Journal of Cancer, vol. 118, no. 12, pp. 3140–3146, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. R. D. Mittal, P. K. Manchanda, S. Bhat, and H. K. Bid, “Association of vitamin-D receptor (Fok-I) gene polymorphism with bladder cancer in an Indian population,” BJU International, vol. 99, no. 4, pp. 933–937, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. A. A. Bhanushali, N. Lajpal, S. S. Kulkarni, S. S. Chavan, S. S. Bagadi, and B. R. Das, “Frequency of fokI and taqI polymorphism of vitamin D receptor gene in Indian population and its association with 25-hydroxyvitamin D levels,” Indian Journal of Human Genetics, vol. 15, no. 3, pp. 108–113, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Garcion, N. Wion-Barbot, C. N. Montero-Menei, F. Berger, and D. Wion, “New clues about vitamin D functions in the nervous system,” Trends in Endocrinology and Metabolism, vol. 13, no. 3, pp. 100–105, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Abe, C. Miyaura, and H. Sakagami, “Differentiation of mouse myeloid leukemia cells induced by 1α,25-dihydroxyvitamin D3,” Proceedings of the National Academy of Sciences of the United States of America, vol. 78, no. 8, pp. 4990–4994, 1981. View at Google Scholar · View at Scopus
  21. P. Naveilhan, F. Berger, K. Haddad et al., “Induction of glioma cell death by 1,25(OH)2 vitamin D3: towards an endocrine therapy of brain tumors?” Journal of Neuroscience Research, vol. 37, no. 2, pp. 271–277, 1994. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Baudet, G. Chevalier, P. Naveilhan, L. Binderup, P. Brachet, and D. Wion, “Cytotoxic effects of 1α,25-dihydroxyvitamin D3 and synthetic vitamin D3 analogues on a glioma cell line,” Cancer Letters, vol. 100, no. 1-2, pp. 3–10, 1996. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Baudet, G. Chevalier, A. Chassevent et al., “1,25-Dihydroxyvitamin D3 induces programmed cell death in a rat glioma cell line,” Journal of Neuroscience Research, vol. 46, no. 5, pp. 540–550, 1996. View at Google Scholar
  24. N. Davoust, D. Wion, G. Chevalier, M. Garabedian, P. Brachet, and D. Couez, “Vitamin D receptor stable transfection restores the susceptibility to 1,25-dihydroxyvitamin D3 cytotoxicity in a rat glioma resistant clone,” Journal of Neuroscience Research, vol. 52, no. 2, pp. 210–219, 1998. View at Google Scholar
  25. P. Trouillas, J. Honnorat, P. Bret, A. Jouvet, and J. P. Gerard, “Redifferentiation therapy in brain tumors: long-lasting complete regression of glioblastomas and an anaplastic astrocytoma under long term 1-alpha-hydroxycholecalciferol,” Journal of Neuro-Oncology, vol. 51, no. 1, pp. 57–66, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. I. Neveu, P. Naveilhan, C. Menaa, D. Wion, P. Brachet, and M. Garabedian, “Synthesis of 1,25-dihydroxyvitamin D3 by rat brain macrophages in vitro,” Journal of Neuroscience Research, vol. 38, no. 2, pp. 214–220, 1994. View at Publisher · View at Google Scholar · View at Scopus
  27. S. A. Miller, D. D. Dykes, and H. F. Polesky, “A simple salting out procedure for extracting DNA from human nucleated cells,” Nucleic Acids Research, vol. 16, no. 3, p. 1215, 1988. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Raimondi, H. Johansson, P. Maisonneuve, and S. Gandini, “Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk,” Carcinogenesis, vol. 30, no. 7, pp. 1170–1180, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. I. Yaylim-Eraltan, H. A. Ergen, S. Arikan et al., “Investigation of the VDR gene polymorphisms association with susceptibility to colorectal cancer,” Cell Biochemistry and Function, vol. 25, no. 6, pp. 731–737, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Eyles, J. Brown, A. Mackay-Sim, J. McGrath, and F. Feron, “Vitamin D3 and brain development,” Neuroscience, vol. 118, no. 3, pp. 641–653, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. E. Giovannucci, “The epidemiology of vitamin D and cancer incidence and mortality: a review (United States),” Cancer Causes and Control, vol. 16, no. 2, pp. 83–95, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. A. L. M. Sutton, X. Zhang, T. I. Ellison, and P. N. MacDonald, “The 1,25(OH)2D3-regulated transcription factor MN1 stimulates vitamin D receptor-mediated transcription and inhibits osteoblastic cell proliferation,” Molecular Endocrinology, vol. 19, no. 9, pp. 2234–2244, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Arai, K. I. Miyamoto, Y. Taketani et al., “A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women,” Journal of Bone and Mineral Research, vol. 12, no. 6, pp. 915–921, 1997. View at Publisher · View at Google Scholar · View at Scopus
  34. N. Swapna, U. M. Vamsi, G. Usha, and T. Padma, “Risk conferred by FokI polymorphism of vitamin D receptor (VDR) gene for essential hypertension,” Indian Journal of Human Genetics, vol. 17, no. 3, pp. 201–206, 2011. View at Publisher · View at Google Scholar
  35. P. W. Jurutka, L. S. Remus, G. K. Whitfield et al., “The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB,” Molecular Endocrinology, vol. 14, no. 3, pp. 401–420, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. E. M. Colin, A. E. A. M. Weel, A. G. Uitterlinden et al., “Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1,25-dihydroxyvitamin D3,” Clinical Endocrinology, vol. 52, no. 2, pp. 211–216, 2000. View at Google Scholar · View at Scopus
  37. C. Sweeney, K. Curtin, M. A. Murtaugh, B. J. Caan, J. D. Potter, and M. L. Slattery, “Haplotype analysis of common vitamin D receptor variants and colon and rectal cancers,” Cancer Epidemiology Biomarkers and Prevention, vol. 15, no. 4, pp. 744–749, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. J. J. McGrath, F. P. Féron, T. H. Burne, A. Mackay-Sim, and D. W. Eyles, “Vitamin D3-implications for brain development,” The Journal of Steroid Biochemistry and Molecular Biology, vol. 89-90, no. 1–5, pp. 557–560, 2004. View at Google Scholar
  39. M. Tseng, R. A. Breslow, B. I. Graubard, and R. G. Ziegler, “Dairy, calcium, and vitamin D intakes and prostate cancer risk in the National Health and Nutrition Examination Epidemiologic Follow-up Study cohort,” American Journal of Clinical Nutrition, vol. 81, no. 5, pp. 1147–1154, 2005. View at Google Scholar · View at Scopus
  40. D. Feskanich, J. Ma, C. S. Fuchs et al., “Plasma vitamin D metabolites and risk of colorectal cancer in women,” Cancer Epidemiology Biomarkers and Prevention, vol. 13, no. 9, pp. 1502–1508, 2004. View at Google Scholar · View at Scopus
  41. K. M. Reilly, “Brain tumor susceptibility: the role of genetic factors and uses of mouse models to unravel risk,” Brain Pathology, vol. 19, no. 1, pp. 121–131, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. X.-B. Jiang, C. Ke, Z.-A. Han et al., “Intraparenchymal papillary meningioma of brainstem: case report and literature review,” World Journal of Surgical Oncology, vol. 10, p. 10, 2012. View at Publisher · View at Google Scholar
  43. A. Mogi, J. Hirato, T. Kosaka, E. Yamaki, and H. Kuwano, “Primary mediastinal atypical meningioma: report of a case and literature review,” World Journal of Surgical Oncology, vol. 21, no. 10, p. 17, 2012. View at Publisher · View at Google Scholar
  44. J. S. Barnholtz-Sloan and C. Kruchko, “Meningiomas: causes and risk factors,” Neurosurgical Focus, vol. 23, no. 4, p. E2, 2007. View at Google Scholar · View at Scopus
  45. B. S. Malmer, M. Feychting, S. Lönn et al., “Genetic variation in p53 and ATM haplotypes and risk of glioma and meningioma,” Journal of Neuro-Oncology, vol. 82, no. 3, pp. 229–237, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. H. J. Ting, S. Yasmin-Karim, S. J. Yan et al., “A positive feedback signaling loop between ATM and the vitamin D receptor is critical for cancer chemoprevention by vitamin D,” Cancer Research, vol. 72, no. 4, pp. 958–968, 2012. View at Publisher · View at Google Scholar
  47. S. Sadetzki, P. Flint-Richter, S. Starinsky et al., “Genotyping of patients with sporadic and radiation-associated meningiomas,” Cancer Epidemiology Biomarkers and Prevention, vol. 14, no. 4, pp. 969–976, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. X. Qi, R. Pramanik, J. Wang et al., “The p38 and JNK pathways cooperate to trans-activate vitamin D receptor via c-Jun/AP-1 and sensitize human breast cancer cells to vitamin D3-induced growth inhibition,” Journal of Biological Chemistry, vol. 277, no. 29, pp. 25884–25892, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Kure, K. Nosho, Y. Baba et al., “Vitamin D receptor expression is associated with PIK3CA and KRAS mutations in colorectal cancer,” Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 10, pp. 2765–2772, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Budhdeo, R. A. Ibrahim, M. Hofer, and M. Gillies, “Primary intraosseous osteoblastic meningioma,” JRSM Short Reports, vol. 2, no. 6, 2011. View at Publisher · View at Google Scholar
  51. M. A. Meester-Smoor, M. Vermeij, M. J. L. van Helmond et al., “Targeted disruption of the Mn1 oncogene results in severe defects in development of membranous bones of the cranial skeleton,” Molecular and Cellular Biology, vol. 25, no. 10, pp. 4229–4236, 2005. View at Publisher · View at Google Scholar · View at Scopus